Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Tax Provisions: 2012-2024

Historic Tax Provisions for Agios Pharmaceuticals (AGIO) over the last 2 years, with Dec 2024 value amounting to -$8.9 million.

  • Agios Pharmaceuticals' Tax Provisions was N/A to -$8.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $43.8 million, marking a year-over-year change of. This contributed to the annual value of $44.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Tax Provisions of -$8.9 million as of Q4 2024, which was down 116.71% from $53.1 million recorded in Q3 2024.
  • Agios Pharmaceuticals' 5-year Tax Provisions high stood at $53.1 million for Q3 2024, and its period low was -$8.9 million during Q4 2024.
  • In the last 1 years, Agios Pharmaceuticals' Tax Provisions had a median value of $22.1 million in 2024 and averaged $22.1 million.